Promotion of Access to Information Act (PAIA)
The PAIA manual is prepared in accordance with section 51 of the Promotion of Access to Information Act (PAIA) No. 2 of 2000 (as amended) and the Protection of Personal Information Act, 2013. The purpose of PAIA is to promote the right of access to information, to foster a culture of transparency and accountability within the Company by giving the right to information that is required for the exercise or protection of any right and to actively promote a society in which the people of South Africa have effective access to information to enable them to exercise and protect their rights.
Please see the PAIA manuals.
S0 Centrum: For a list of ingredients refer to product labelling. Complementary medicines – Health Supplement. This unregistered medicine has not been evaluated by the SAHPRA for its quality, safety or intended use. GlaxoSmithKline Consumer Healthcare South Africa (Pty) Ltd. 39 Hawkins Avenue, Epping Industria 1, Cape Town, 7460. Reg. No: 2014/173930/07. For full prescribing information refer to the patient information leaflet
For any further information, including safety, please contact the GSK Hotline on +27 11 745 6001 or 0800 118 274.
Read label before use
Trademarks are owned by or licensed to GSK group of companies.
Please report any adverse events to aereporting.za@gsk.com
© 2020 GSK group of companies. All rights reserved. The content of this site is intended for South Africa audiences only.
PM-ZA-CNT-21-00014